Point72 Middle East FZE’s Relmada Therapeutics RLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,313	Closed	-$5.69K	–	1316
2023 Q2	$5.69K	Buy	+2,313	New	+$5.69K	﹤0.01%	895
2023 Q1	–	Sell	-15,517	Closed	-$54.2K	–	1547
2022 Q4	$54.2K	Buy	+15,517	New	+$54.2K	﹤0.01%	896